DynaKin offers a wide range of services and products within the scientific field of Pharmacokinetics (PK) and pharmacodynamics (PD). Our service options can be individually tailored to suit the needs of each client. They include:

Pharmacokinetic and/or Pharmacodynamic studies
DynaKin’ Drug Modeling & Simulation (DMC) group offers a comprehensive solution for data analysis from any of the phases of the drug development process. Our services allow a better understanding of the behavior of a given drug using a small sample size with consequent time and cost savings. Our services include population pharmacokinetic (PK), pharmacodynamic (PD) and PK/PD analysis, Modelling and Simulation. The professional expertise of DynaKin in this area covers:
Study Design; Protocol development; Bioanalytical services; Biostatistics; Final Report; Regulatory submission.

Assistance through all stages of the drug development process
DMC operates under the MBDD, translational medicine principles providing integration of knowledge across all stages of drug R&D:
Fundamental research; Preclinical: Toxicokinetics; Clinical (Phase I, II, III); Post-marketing Studies.

Bioequivalence
DynaKin performs studies intended for the recognition of a potential to-be-marketed generic product, providing: Study Design; Protocol development; Bioanalytical services; Biostatistics; Final report.

Therapeutic Drug Monitoring (TDM)
At DynaKin, we collaborate with hospital services in TDM for drugs with a narrow therapeutic range to achieve the desired effect while avoiding toxicity.

Personalized therapy
Our experts work on the design of devices that allow an individualization of the dose in each patient, according to genetic polymorphisms obtaining: Improvement of the quality of life of patients by reducing side effects; Appropriate selection, prescription and dosage of a drug; Reduction in health expenditures by optimizing drug consumption.